Navigation Links
Cancer Risk Cited From Radiation In New Procedures

A new Health Canada document available with CanWest News Service suggests that reducing the dose of radiation for patients //could "translate in the saving of 125 lives per year." It is estimated that cancers caused by X-rays kill 780 to 2,500 Canadians a year.

Health Canada also said that many new devices that use X-rays to push thin tubes into arteries and blood vessels have not been sufficiently tested and their efficacy and safety remains unknown.

"In general, these procedures are of benefit to Canadians since they allow a shorter stay in hospital and reduce the need for surgery. However, the risks of cancer and deterministic effects (injuries) are not negligible," the document that was obtained by Ottawa researcher Ken Rubin, said.

The report adds that nearly three million Canadians will have a CT scan of their brain, lungs, joints, stomachs or other organs annually and thousands will have an angioplasty or other X-ray guided procedures for various problems like clogged arteries. While the benefits of these procedures are not disputed, Health Canada says the safety remains a problem.

Dr. Richard Semelka, professor and vice-chair of research in University of North Carolina's department of radiology agreed with the document's findings. "They undergo a CT, but nobody says to them that there is a small but definite risk you could get cancer. And I think that is wrong."

But Dr. Benjamin Chow, a cardiologist at the University of Ottawa Heart Institute, said the risk of cancer was very minimal, "Twenty-five per cent of the population will get cancer -- one in four. So you're increasing their risk of cancer from 25 per cent to 25.001 per cent," he said. "From a medical perspective, we don't think this is a significant increase in risk."


'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
(Date:5/16/2008)...sents Urban Health Institute with 10,000 Sensual O...rg at Playboy Mansion Fundraiser, LOS ANGELES, Ma...ip-hop,and R & B artist J Kwon known best for his ...ll be presenting the Urban Health Institute (UHI) ... over $50,000. The donation is,being made to promo...
(Date:5/16/2008)...docs determine who would benefit most from chemo a... 16 (HealthDay News) -- A panel of 15 genes may he...mall cell lung cancer will experience a recurrence...y, a new study shows. , By extension, the same... less aggressive forms of the cancer who would be ...
(Date:5/16/2008)...TON, May 16 /PRNewswire-USNewswire/ -- As tropical...e Irrawaddy delta, survivors of,Cyclone Nargis are... Many,survivors still need assistance, as exposure... an increasingly dire situation., "The people liv...,recover from this disaster and get back on their ...
(Date:5/16/2008)...h Funding Per Death Drops More in 2007, WASHINGTO...ncer causes,one in three cancer deaths, the Nation... its $4.8 billion budget in lung cancer research i...Lung Cancer Alliance (LCA) today., The two other ...programs -- Centers for Disease Control and Preven...
Breaking Medicine News(10 mins):Health News:Everybody in the Club Scream O! 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Lung Cancer Still Lowest in Federal Funding 2
...iRNAs) belong to the newly discovered group of gen... Carolina have discovered two genes // belonging t...er attributed to the proper development of muscles... initially discovered (1993) in the genome of the ...
...H5N1 bird flu infection occurred from Qinghai Lake...nese officials have confirmed // the seventh death...ictim, Zhou was a 41 year old women factory worker...ng symptoms of fever and pneumonia, who had an ini...
...b-standard poultry vaccine, which would explain re...n poultry, experts feel // . The fear among exper...hat largely affects birds to one that can pass eas...a human pandemic. Since late 2003, there have bee...
...December 29 issue of the New England Journal of Me...tter than tamoxifen fro preventing the chances // ...nufactured by Novartis AG and is chemically letroz...called as the aromatase inhibitors of which Arimid...
Other Medicine News:Health News:Genetic mystery behind muscle development unraveled. 2Health News:Bad vaccines may trigger China bird flu 2
(Date:5/15/2008)...ase II Data Presented at ASCO Showed Acceptable To... of Grade 3 and 4 Neuropathy, WOODCLIFF LAKE, N.J...otherapeutic agent eribulin mesylate (E7389) demon...n of women with locally advanced or metastatic,bre... Phase II clinical,trial. The study also suggests ...
(Date:5/15/2008)...BRIDGEWATER, N.J., May 15 /...ounced today that findings from the,landmark ATHEN...l therapy,for the treatment of patients with atria...sk of cardiovascular hospitalizations or death fro...0.00000002), meeting the study,primary endpoint. T...
(Date:5/15/2008)...BONITA SPRINGS, Fla., May 15 /- Tigri...ion of a Cooperative Research and,Development Agre...NCI) to,collaborate on clinical and preclinical de... Phase I development. AFP-464 is converted to,meta... p53 activation and,apoptosis., This is part of a...
(Date:5/15/2008)...Randomized TRIAS HR Pilot Study Compares Genous, B...Taxus(R), Other Presentations Focus on Real-World ...th AMI, Those Who Could Not Tolerate Dual-Antiplat...ELONA, Spain, May 15 /- OrbusNeich to...tions in a symposium at EuroPCR 2008,support the u...
Breaking Medicine Technology:Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Alcons PATANASE 28R 29 Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 16920 1Alcons PATANASE 28R 29 Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 16920 2Alcons PATANASE 28R 29 Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 16920 3Alcons PATANASE 28R 29 Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 16920 4Press Preview to Unveil Miracle Manny 16916 1Susan Byrne joins GHG Grey Healthcare Group as EVP Strategy and Business Development Europe a Newly Created Position 16911 1Susan Byrne joins GHG Grey Healthcare Group as EVP Strategy and Business Development Europe a Newly Created Position 16911 2Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimers Disease 4627 1Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimers Disease 4627 2Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimers Disease 4627 3Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimers Disease 4627 4Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimers Disease 4627 5
... 2007 /PRNewswire-FirstCall/ --,Lexicon Pharmaceut... findings from a joint research project with scien...PA. Together with David L.,Wiest, Ph.D., Lexicon r...role for ribosomal protein L22 (Rpl22) in the,deve... published in,the June issue of the journal Immuni...
...duction in sedation during the,early post-operativ...gnificant reduction in nausea in the female,patien... 8th June 2007 - CeNeS Pharmaceuticals plc (AIM:,C..., announces,additional data from post-hoc analysis...rphine-6-glucuronide) in over 500 patients,with po...
Other Medicine Technology:Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 2Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7
The dual-electrode SPL defibrillator lead features a patented coiled-coil electrode design, offering the flexibility and maneuverability of a pacemaker lead. Designed for the physician who prefers a
TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e
...ar-spaced electrodes along a circular tip, providi...ial fibrillation procedures. High resolution mappi...npointing of pulmonary vein potentials than with 1...iency in the catheter-based management of atrial f...
Medicine Products: